B. Haag

592 total citations
21 papers, 412 citations indexed

About

B. Haag is a scholar working on Surgery, Transplantation and Nephrology. According to data from OpenAlex, B. Haag has authored 21 papers receiving a total of 412 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Surgery, 6 papers in Transplantation and 5 papers in Nephrology. Recurrent topics in B. Haag's work include Renal Transplantation Outcomes and Treatments (6 papers), Renal Diseases and Glomerulopathies (5 papers) and Organ Transplantation Techniques and Outcomes (5 papers). B. Haag is often cited by papers focused on Renal Transplantation Outcomes and Treatments (6 papers), Renal Diseases and Glomerulopathies (5 papers) and Organ Transplantation Techniques and Outcomes (5 papers). B. Haag collaborates with scholars based in United States and Canada. B. Haag's co-authors include Richard S. Mangus, J. Richard Thistlethwaite, A. Osama Gaber, Andrew J. Aronson, Charles W. Carter, W. Pagé Faulk, C. E. Broelsch, F. P. Stuart, Carlos A. Labarrere and Ronald J. Torry and has published in prestigious journals such as Transplantation, American Journal of Transplantation and International Archives of Allergy and Immunology.

In The Last Decade

B. Haag

21 papers receiving 394 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B. Haag United States 11 172 132 127 96 79 21 412
Peter Dupont United Kingdom 11 103 0.6× 50 0.4× 149 1.2× 84 0.9× 41 0.5× 23 382
Hideari Ihara Japan 10 122 0.7× 45 0.3× 141 1.1× 152 1.6× 72 0.9× 46 453
T Agishi Japan 13 66 0.4× 106 0.8× 245 1.9× 264 2.8× 28 0.4× 72 581
Yoriaki Kamiryo Japan 11 137 0.8× 105 0.8× 229 1.8× 365 3.8× 35 0.4× 28 579
Birgitta Kranz Germany 15 74 0.4× 86 0.7× 145 1.1× 95 1.0× 66 0.8× 22 618
Susana Machado Portugal 8 41 0.2× 67 0.5× 46 0.4× 56 0.6× 32 0.4× 45 314
Julien Branchereau France 14 188 1.1× 140 1.1× 238 1.9× 392 4.1× 42 0.5× 97 718
William A. Kisken United States 14 143 0.8× 138 1.0× 80 0.6× 267 2.8× 38 0.5× 28 536
Joshua Kausman Australia 15 93 0.5× 54 0.4× 208 1.6× 126 1.3× 109 1.4× 35 692
Noosha Baqi United States 11 47 0.3× 92 0.7× 71 0.6× 48 0.5× 32 0.4× 18 433

Countries citing papers authored by B. Haag

Since Specialization
Citations

This map shows the geographic impact of B. Haag's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Haag with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Haag more than expected).

Fields of papers citing papers by B. Haag

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Haag. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Haag. The network helps show where B. Haag may publish in the future.

Co-authorship network of co-authors of B. Haag

This figure shows the co-authorship network connecting the top 25 collaborators of B. Haag. A scholar is included among the top collaborators of B. Haag based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Haag. B. Haag is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mangus, Richard S. & B. Haag. (2004). Stented versus Nonstented Extravesical Ureteroneocystostomy in Renal Transplantation: A Metaanalysis. American Journal of Transplantation. 4(11). 1889–1896. 147 indexed citations
2.
Mangus, Richard S., et al.. (2004). Stented Lich–Gregoir ureteroneocystostomy: Case series report and cost-effectiveness analysis. Transplantation Proceedings. 36(10). 2959–2961. 16 indexed citations
3.
Wagenknecht, Dawn R., et al.. (2000). Risk of early renal allograft failure is increased for patients with antiphospholipid antibodies. Transplant International. 13(0). S78–S81. 16 indexed citations
4.
Wagenknecht, Dawn R., et al.. (2000). Risk of early renal allograft failure is increased for patients with antiphospholipid antibodies. Transplant International. 13(S1). S78–S81. 9 indexed citations
5.
Wagenknecht, Dawn R., et al.. (1999). Antiphospholipid antibodies are a risk factor for early renal allograft failure: isolation of antiphospholipid antibodies from a thrombosed renal allograft. Transplantation Proceedings. 31(1-2). 285–288. 16 indexed citations
6.
Torry, Ronald J., Carlos A. Labarrere, David Nelson, et al.. (1998). TUBULAR ANTITHROMBIN AT TRANSPLANTATION DETERMINES SUBSEQUENT RENAL ALLOGRAFT FUNCTION1,2. Transplantation. 66(6). 797–799. 8 indexed citations
7.
Liu, Chi, Locksley E. McGann, Dayong Gao, B. Haag, & John K. Critser. (1996). Osmotic Separation of Pancreatic Exocrine Cells from Crude Islet Cell Preparations. Cell Transplantation. 5(1). 31–39. 6 indexed citations
8.
Liu, Chi, Charles Benson, Dayong Gao, et al.. (1995). Water Permeability and Its Activation Energy for Individual Hamster Pancreatic Islet Cells. Cryobiology. 32(5). 493–502. 37 indexed citations
9.
Taber, Tim E., et al.. (1995). Maintenance of Adequate Hemodialysis Access. ASAIO Journal. 41(4). 842–846. 14 indexed citations
10.
Bukovský, Antonín, Carlos A. Labarrere, Charles W. Carter, B. Haag, & W. Pagé Faulk. (1992). NOVEL IMMUNOHISTOCHEMICAL MARKERS OF HUMAN RENAL ALLOGRAFT DYSFUNCTION—ANTITHROMBIN III, THY-1, UROKINASE, AND ALPHA–SMOOTH MUSCLE ACTIN. Transplantation. 54(6). 1064–1070. 9 indexed citations
11.
Labarrere, Carlos A., et al.. (1992). THE ENDOTHELIAL HEPARAN SULFATE-ANTITHROMBIN III NATURAL ANTICOAGULANT PATHWAY IN NORMAL AND TRANSPLANTED HUMAN KIDNEYS. Transplantation. 53(4). 828–833. 22 indexed citations
12.
Bukovský, Antonín, Carlos A. Labarrere, B. Haag, Charles W. Carter, & W. Pagé Faulk. (1992). TISSUE FACTOR IN NORMAL AND TRANSPLANTED HUMAN KIDNEYS. Transplantation. 54(4). 644–650. 11 indexed citations
13.
Gaber, A. Osama, B. Haag, Andrew J. Aronson, et al.. (1987). OKT3 TREATMENT OF STEROID-RESISTANT RENAL ALLOGRAFT REJECTION. Transplantation. 43(2). 176–183. 66 indexed citations
14.
Gaber, A. Osama, J. Richard Thistlethwaite, B. Haag, et al.. (1987). Potent immunosuppression overcomes retransplantation, presensitization, and historical positive crossmatch as transplant risk factors.. PubMed. 19(1 Pt 3). 1915–6. 3 indexed citations
15.
Gaber, A. Osama, et al.. (1987). Intermediate normothermic hemoperfusion doubles safe cold preservation of rat kidneys.. PubMed. 19(1 Pt 2). 1369–71. 1 indexed citations
16.
Thistlethwaite, J. Richard, B. Haag, A. Osama Gaber, et al.. (1987). The use of OKT3 to treat steroid-resistant renal allograft rejection in patients receiving cyclosporine.. PubMed. 19(1 Pt 3). 1901–4. 15 indexed citations
17.
Gaber, A. Osama, J. Richard Thistlethwaite, B. Haag, et al.. (1987). Potent immunosuppression overcomes immunologic high-risk factors in recipients of cadaveric renal allografts.. PubMed. 53(7). 407–9. 1 indexed citations
18.
Thistlethwaite, J. Richard, B. Haag, Kenneth W. Jones, J Stuart, & Frank P. Stuart. (1985). Elective conversion from cyclosporine to azathioprine in recipients with stable renal function 6 months after kidney transplantation. Human Immunology. 14(3). 314–323. 11 indexed citations
19.
Ahlstedt, S., et al.. (1980). Antigenic High Molecular Weight Material in Penicillin Preparations. International Archives of Allergy and Immunology. 63(3). 344–346. 2 indexed citations
20.
Cassani, Stefano, et al.. (1973). [Apparatus after-control in urinary incontinence surgery].. PubMed. 13. Suppl 1:101–2. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026